These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 20529796)

  • 1. Biphasic and delayed hypersensitivity reactions.
    Viale PH; Yamamoto DS
    Clin J Oncol Nurs; 2010 Jun; 14(3):347-56. PubMed ID: 20529796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management and preparedness for infusion and hypersensitivity reactions.
    Lenz HJ
    Oncologist; 2007 May; 12(5):601-9. PubMed ID: 17522249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid desensitization for hypersensitivity reactions to chemotherapy agents.
    Castells M
    Curr Opin Allergy Clin Immunol; 2006 Aug; 6(4):271-7. PubMed ID: 16825867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of hypersensitivity reactions: a nursing perspective.
    Viale PH
    Oncology (Williston Park); 2009 Feb; 23(2 Suppl 1):26-30. PubMed ID: 19385164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of a protocol to minimize hypersensitivity reactions with asparaginase administration.
    Bryant R
    J Intraven Nurs; 2001; 24(3):169-73. PubMed ID: 11530362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infusion reactions: diagnosis, assessment, and management.
    Vogel WH
    Clin J Oncol Nurs; 2010 Apr; 14(2):E10-21. PubMed ID: 20350882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed onset and protracted progression of anaphylaxis after omalizumab administration in patients with asthma.
    Limb SL; Starke PR; Lee CE; Chowdhury BA
    J Allergy Clin Immunol; 2007 Dec; 120(6):1378-81. PubMed ID: 17936893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of infusion reactions on oncology patients and clinicians in the inpatient and outpatient practice settings: oncology nurses' perspectives.
    Colwell HH; Mathias SD; Ngo NH; Gitlin M; Lu ZJ; Knoop T
    J Infus Nurs; 2007; 30(3):153-60. PubMed ID: 17505216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Best practices in multiple sclerosis: infusion reactions versus hypersensitivity associated with biologic therapies.
    Namey M; Halper J; O'leary S; Beavin J; Bishop C
    J Infus Nurs; 2010; 33(2):98-111. PubMed ID: 20228647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omalizumab-associated anaphylactic reactions reported between January 2007 and June 2008.
    Lin RY; Rodriguez-Baez G; Bhargave GA
    Ann Allergy Asthma Immunol; 2009 Nov; 103(5):442-5. PubMed ID: 19927545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Infusion reactions].
    Sato K; Kohgo Y
    Gan To Kagaku Ryoho; 2008 Oct; 35(10):1671-4. PubMed ID: 18931569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical predictors for biphasic reactions in children presenting with anaphylaxis.
    Mehr S; Liew WK; Tey D; Tang ML
    Clin Exp Allergy; 2009 Sep; 39(9):1390-6. PubMed ID: 19486033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biphasic anaphylactic reactions.
    Lieberman P
    Ann Allergy Asthma Immunol; 2005 Sep; 95(3):217-26; quiz 226, 258. PubMed ID: 16200811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid drug desensitization for hypersensitivity reactions to chemotherapy and monoclonal antibodies in the 21st century.
    Castells Guitart MC
    J Investig Allergol Clin Immunol; 2014; 24(2):72-9; quiz 2 p following 79. PubMed ID: 24834769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nursing care strategies for the management of side effects in patients treated for colorectal cancer.
    Taplin SC; Blanke CD; Baughman C
    Semin Oncol; 1997 Oct; 24(5 Suppl 18):S18-64-S18-70. PubMed ID: 9420023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing premedications and the risk for reactions to infusional monoclonal antibody therapy.
    Chung CH
    Oncologist; 2008 Jun; 13(6):725-32. PubMed ID: 18586928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biphasic anaphylaxis: review of incidence, clinical predictors, and observation recommendations.
    Tole JW; Lieberman P
    Immunol Allergy Clin North Am; 2007 May; 27(2):309-26, viii. PubMed ID: 17493505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine-release syndrome: overview and nursing implications.
    Breslin S
    Clin J Oncol Nurs; 2007 Feb; 11(1 Suppl):37-42. PubMed ID: 17471824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and characteristics of biphasic anaphylaxis: a prospective evaluation of 103 patients.
    Ellis AK; Day JH
    Ann Allergy Asthma Immunol; 2007 Jan; 98(1):64-9. PubMed ID: 17225722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and characteristics of biphasic reactions after allergen immunotherapy.
    Scranton SE; Gonzalez EG; Waibel KH
    J Allergy Clin Immunol; 2009 Feb; 123(2):493-8. PubMed ID: 19064282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.